Clinically relevant cholesterol elevation in anxiety disorders: A comparison with normal controls

  • Helmut Peter
  • Philipp Goebel
  • Susanne Müller
  • Iver Hand
Article

Abstract

Recently, several studies reported elevated cholesterol levels in panic disorder, agoraphobia, and general anxiety disorder, but the clinical relevance is still unsettled. All studies so far have disregarded the possible influence of dietary and physical exercise factors. In this study, 30 patients with different anxiety disorders and 30 normal controls were compared for total cholesterol, low-density lipoprotein (LDL), and cholesterol/high-density lipoprotein (HDL) ratio. Dietary and physical exercise habits were measured by self-rating questionnaires. Patients with anxiety disorders had significantly elevated total cholesterol, LDL, and cholesterol/HDL ratios. Patients showed borderline-high or high cholesterol levels almost 3 times as often as control participants. Anxiety-specific avoidance of physical exercise and special dietary habits of anxiety patients had a significant but minor impact on differences in cholesterol between both groups. Our data support the assumption that serum cholesterol elevations in anxiety disorder patients are within a clinically relevant range.

Key words

anxiety disorders cholesterol LDL cholesterol/HDL ratio physical exercise dietary habits 

References

  1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed). Washington, DC: Author.Google Scholar
  2. Bajwa, W. K., Asnis, G. M., Sanderson, W. C, Irfan, A., & van Praag, H. M. (1992). High cholesterol levels in patients with panic disorder. American Journal of Psychiatry, 149, 376–378.PubMedGoogle Scholar
  3. Brindley, D. N., McCann, B. S., Niaura, R., Stoney, C. M., & Suarez, E. C. (1993). Stress and lipoprotein metabolism: Modulators and mechanisms. Metabolism, 42, 3–15.PubMedCrossRefGoogle Scholar
  4. Charney, D. S., & Redmond, D. E. (1983). Neurobiologic mechanisms in human anxiety: Evidence supporting central noradrenergic hyperactivity. Neuropharmacology, 22, 1531–1536.PubMedCrossRefGoogle Scholar
  5. Coryell, W. (1988). Panic disorder and mortality. Psychiatric Clinics of North America, 11, 433–440.PubMedGoogle Scholar
  6. Coryell, W., Noyes, R., & Clancy, J. (1982). Excess mortality in panic disorder: A comparison with unipolar depression. Archives of General Psychiatry, 39, 701–703.PubMedGoogle Scholar
  7. Coryell, W., Noyes, R., & House, J. D. (1986). Mortality among outpatients with anxiety disorders. American Journal of Psychiatry, 143, 508–510.PubMedGoogle Scholar
  8. Dimsdale, J. E., & Herd, J. A. (1982). Variability of plasma lipids in response to emotional arousal. Psychosomatic Medicine, 44, 413–429.PubMedGoogle Scholar
  9. The Expert Panel. (1988). Report of the national education program: Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Archives of Internal Medicine, 148, 36–69.CrossRefGoogle Scholar
  10. Freedman, D. S., Byers, T., Barrett, D. H., Stroup, N. E., Eaker, E., & Monroe-Blum, H. (1995). Plasma lipid levels and psychological characteristics in men. American Journal of Epidemiology, 141, 507–517.PubMedGoogle Scholar
  11. Friedewald, W. T., Levy, R. I., & Fredickson, D. S. (1972). Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clinical Chemistry, 18, 499–502.PubMedGoogle Scholar
  12. Haines, A. P., lmeson, J. D., & Meade, T. W. (1987). Phobic anxiety and ischaemic heart disease. British Medical Journal, 295, 297–299.PubMedCrossRefGoogle Scholar
  13. Hayward, C, Taylor, C. B., Roth, W. T., King, R., & Agras, W. S. (1989). Plasma lipid levels in patients with panic disorder or agoraphobia. American Journal of Psychiatry, 146, 917–919.PubMedGoogle Scholar
  14. Hopkins, P. N. (1992). Effects of dietary cholesterol on serum cholesterol: A meta-analysis and review. American Journal of Clinical Nutrition, 55, 1060–1070.PubMedGoogle Scholar
  15. Kristal, A. R., Shattuck, A. L., Henry, H. J., & Fowler, A. S. (1990). Rapid assessment of dietary intake of fat, fiber, and saturated fat: Validity of an instrument for community intervention research and nutritional surveillance. American Journal of Health Promotion, 4, 288–295.Google Scholar
  16. Kuczmierczyk, A. R., Barbee, J. G., Bologna, N. A., & Townsend, M. H. (1996). Serum cholesterol levels in patients with generalized anxiety disorder (GAD) and with GAD and comorbid major depression. Canadian Journal of Psychiatry, 41, 465–468.Google Scholar
  17. Martin, M. J., Hulley, S. B., Browner, W. S., Kuller, L. H., & Wentworth, D. (1986). Serum cholesterol, blood pressure and mortality: Implications from a cohort of 361,662 men. Lancet, 2, 933–936.PubMedCrossRefGoogle Scholar
  18. Martin, R. L., Cloninger, C. R., Guze, S. B., & Clayton, P. J. (1985). Mortality in a follow-up of 500 psychiatric outpatients. Archives of General Psychiatry, 42, 47–71.PubMedGoogle Scholar
  19. Nesse, R. M., Cameron, O. G., Curtis, G. C., McCann, D. S., & Huber-Smith, M. J. (1984). Adrenergic function in patients with panic anxiety. Archives of General Psychiatry, 41, 771–776.PubMedGoogle Scholar
  20. Niaura, R., Stoney, C. M., & Herbert, P. N. (1992). Lipids in psychological research: The last decade. Biological Psychology, 34, 1–43.PubMedCrossRefGoogle Scholar
  21. O’Donnell, L., Owens, D., McGee, C., Devery, R., Hession, P., Collins, P., Johnson, A., & Tomkin, G. (1988). Effects of catecholamines on serum lipoproteins of normally fed and cholesterol-fed rabbits. Metabolism, 37, 910–915.PubMedCrossRefGoogle Scholar
  22. Reifman, A., & Windle, M. (1993). High cholesterol levels in patients with panic disorder. American Journal of Psychiatry, 150, 527.PubMedGoogle Scholar
  23. Spielberger, C. D., Gorusch, R. L., & Luschene, R. E. (1970). State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.Google Scholar
  24. Tancer, M. E., Stein, M. B., Moul, D. E., & Uhde, T. U. (1990). Normal serum cholesterol in panic disorder. Biological Psychiatry, 27, 99–101.PubMedCrossRefGoogle Scholar
  25. Tran, Z. V., & Weltman, A. (1985). Differential effects of exercise on serum lipid and lipoprotein levels seen with changes in body weight: A meta-analysis. Journal of the American Medical Association, 254, 919–924.PubMedCrossRefGoogle Scholar
  26. Villacres, E. C, Hollifield, M., & Kanton, W. J. (1987). Sympathic nervous system activity in panic disorder. Psychiatry Research, 21, 313–321.PubMedCrossRefGoogle Scholar
  27. Weissman, M. M., Markowitz, J. S., Ouelette, R., Greenwald, S., & Kahn, J. P. (1990). Panic disorder and cardiovascular/cerebrovascular problems: Results from a community survey. American Journal of Psychiatry, 147, 1504–1508.PubMedGoogle Scholar
  28. Yeragani, V. K., Pohl, R., Balon, R., Ramesh, C., Glitz, D., & Sherwood, P. (1990). Risk factors for cardiovascular illness in panic disorder patients. Neuropsychobiology, 23, 134–139.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Behavioral Medicine 1999

Authors and Affiliations

  • Helmut Peter
    • 1
  • Philipp Goebel
    • 1
  • Susanne Müller
    • 1
  • Iver Hand
    • 1
  1. 1.Department of PsychiatryUniversity of HamburgHamburgGermany

Personalised recommendations